PREVIOUS PAPERS

See the video on Youtube

Konu YR. et al.
Pharmaco-virological outcomes and genotypic resistance profiles among children and adolescents receiving a DTG-based regimen in Togo.
Clin. Infect. Dis. 2024 May 15
Guhl M. et al.
Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm.
AAPS J.2024 Apr 23
Sonneville R. et al.
Restrictive use of Restraints and Delirium Duration in the Intensive Care Unit (R2D2-ICU): protocol for a French multicentre parallel-group open-label randomised controlled trial.
BMJ Open. 2024 Apr 17
Mallart E. et al.
Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model.
J Antimicrob Chemother. 2024 May 2
d’Humières C. et al.
Perturbation and resilience of the gut microbiome up to 3 months after β-lactams exposure in healthy volunteers suggest an important role of microbial β-lactamases.
Microbiome 2024 Mar 12
Gschwind R. et al.
Inter-phylum circulation of a beta-lactamase-encoding gene: a rare but observable event.
Antimicrob. Agents Chemother. 2024 Mar 5
Lavalley-Morelle A. et al.
Extending the code in the open-source saemix package to fit joint models of longitudinal and time-to-event data.
Comput Methods Programs Biomed. 2024 Feb 23.
Fafi I. et al.
Evolution of respiratory syncytial virus burden in young children following the COVID-19 pandemic: influence of concomitant changes in testing practices.
Lancet Infect. Dis. 2024 Feb 15
Couce A.et al.
Changing fitness effects of mutations through long-term bacterial evolution.
Science. 2023 Dec 21
Birgy A. et al.
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate.
Antimicrob. Agents Chemother. 2024 Jan 23
Sokal A. et al.
Clinical and Bacteriological Specificities of Escherichia coli Bloodstream Infections From Biliary Portal of Entries.
J. Infect. Dis. 2024 Jan 12
Barbier F. et al.
Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study.
Crit. Care. 2024 Jan 3
Nguyen B. et al.
Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.
PLoS Comput Biol. 2023 Dec 21
Rybak A. et al.
Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis.
Clin. Infect. Dis. 2023 Dec 6
Senelle G. et al.
Towards the reconstruction of a global TB history using a new pipeline « TB-Annotator ».
Tuberculosis (Edinb). 2023 Nov 25
Guilbaud R. et al.
Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study.
J. Infect. Dis. 2023 Nov 13
Mimram L. et al.
What clindamycin dose should be administered by continuous infusion during combination therapy with rifampicin? A prospective population pharmacokinetics study
J. Antimicrob Chemother. 2023 Oct 26
Sahal MR. et al.
Mycobacterium tuberculosis complex drug-resistance, phylogenetics, and evolution in Nigeria: Comparison with Ghana and Cameroon.
PLoS Negl. Trop. Dis. 2023
Choudhury A. et al.
Deep mutational scanning reveals the molecular determinants of RNA polymerase-mediated adaptation and tradeoffs.
Nat. Commun. 2023 Oct 9
Gaschignard J. et al.
Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014-2019.
Pediatrics. 2023 Oct 1
Néant N. et al.
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
CPT Pharmacometrics Syst. Pharmacol. 2023 Sep 20
Allain M. et al.
Dissemination of IncI plasmid encoding bla CTX-M-1 is not hampered by its fitness cost in the pig’s gut.
Antimicrob Agents Chemother. 2023 Sep 13
Sylvie C. et al.
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial capacity to cause bloodstream infections in humans.
Ann Intensive Care. 2023 Aug 27
Tran A. et al.
Prevalence and associated factors of antibiotic exposure during pregnancy in a large French population-based study during the 2010-19 period.
J. Antimicrob Chemother. 2023 Aug 25
Marc A. et al.
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.
PLoS Comput. Biol. 2023 Aug 9
Clairon Q. et al.
Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2.
PLoS Comput. Biol. 2023 Aug 7
Burgaya J. et al.
The bacterial genetic determinants of Escherichia coli capacity to cause bloodstream infections in humans.
PLoS Genet. 2023 Aug 2
Thy T. et al.
Comparison between targeted and vaccinated populations during the mpox vaccination campaign in France.
Clin. Microbiol. Infect.2023 Jul 7
Cotto O. et al.
Within-host density and duration of colonization of travel-acquired multidrug-resistant Enterobacterales in untreated individuals.
Clin. Infect. Dis. 2023 Jun 23
Royer G. et al.
Epistatic interactions between the high pathogenicity island and other iron uptake systems shape Escherichia coli extra-intestinal virulence.
Nat. Commun. 2023 Jun 20
Goulenok T. et al.
Pharmacokinetic Interaction between Rifampicin and Clindamycin in Staphylococcal Osteoarticular Infections.
Int. J. Antimicrob. Agents. 2023 Jun 9
Buetti N. et al.
Risk of infections in intravascular catheters in situ for more than 10 days: a post hoc analysis of randomized controlled trials.
Clin. Microbiol. Infect. 2023 May 26
Henoun Loukili N. et al.
Time to intestinal clearance of carbapenemase-producing Enterobacterales in hospital patients: a longitudinal retrospective observational cohort study.
J. Hosp. Infect. 2023 May
Tardivon C. et al.
ResFinderFG v2.0: a database of antibiotic resistance genes obtained by functional metagenomics.
Nucleic Acids Res. 2023 May 19
Tardivon C. et al.
Evaluation of model-based bioequivalence approach for single sample pharmacokinetic studies.
CPT Pharmacometrics Syst. Pharmacol. 2023 Avr 27
Coppée R. et al.
Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020.
Elife. 2023 Avr 26
Quagliaro P. et al.
Performances of bioinformatics tools for the analysis of sequencing data of Mycobacterium tuberculosis complex strains.
Tuberculosis (Edinb). 2023 Mar
Lafaurie M. et al.
Antimicrobial for 7 or 14 days for febrile urinary tract infection in men: a multicenter noninferiority double blind placebo-controlled, randomized clinical trial.
Clin. Infect. Dis. 2023 Feb 14
Gamblin J. et al.
Bottlenecks can constrain and channel evolutionary paths.
Genetics. 2023 Feb 2
Bouzid D. et al.
Agreement of respiratory viruses’ detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study.
Clin Microbiol Infect. 2023 Jan 25
Bachelard A. et al.
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055.
J. Antimicrob. Chemother. 2023 Jan 20
Maalej NH. et al.
Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine.
J. Hepatol. 2023 Jan 17